{"id":"https://genegraph.clinicalgenome.org/r/031c870b-0e47-4c9c-ac63-d3c041e29c80v1.0","type":"EvidenceStrengthAssertion","dc:description":"The coiled-coil domain containing 65 gene (*CCDC65*) encodes a component of the nexin-dynein regulatory complex (N-DRC), a structure that links the outer doublet microtubules of the axoneme and regulates dynein motor activity in cilia and flagella (PMID: 25411337). CDCC65 has also been identified as a human sperm tail protein (PMID: 37975235, PMID: 17089017). *CCDC65* was first reported in relation to PCD in 2013 by Austin-Tse et al. and Horani et al. (PMID: 24094744, PMID: 23991085). The two groups reported a homozygous 2-bp (c.877_878del) deletion in 4 probands of Ashkenazi-Jewish descent and a PCD-consistent phenotype without laterality defects. The variant causes a premature termination codon 2 amino acids downstream (p.Ile293Profs2Ter) that is predicted to result in nonsense-mediated decay, consistent with the decreased expression of CCDC65 revealed by immunofluorescent staining in nasal epithelial cells. On the other hand, the minor allele frequency of 0.004339 in the Ashkenazi Jewish population of the gnomAD database suggests a founder effect. CCDC65 deficiency was also shown to result in loss of GAS8, another component of the N-DRC (PMID: 23991085) that has similarly been linked to PCD (PMID: 26387594 27120127 27472056). Affected patients also had cilia with a reduced inner dynein arms and nexin link, and disorganization of the microtubules, as well as stiff and hyperkinetic cilia with a limited ciliary stroke (PMID: 24094744 and PMID: 23991085). Other studies have reported homozygous *CCDC65* variants in probands with infertility due to aszthenospermia, exhibiting short, absent, and coiled flagella and near-absence of CDCC65 protein (PMID: 37975235), as well as in patients from PCD cohorts harboring apparent loss-of-function variants in *CCDC65* in the homozygous state (PMID: 33479112, PMID: 39004944).\n \nThis gene-disease association is supported by experimental evidence including enriched gene expression in PCD-relevant human tissues (testis, fallopian tubes, and lung). CCDC65 has been detected during early ciliated cell differentiation, coinciding with the expression of the master ciliogenesis gene, *FOXJ1* (PMID: 23991085).  Expression of the CCDC65 ortholog DRC2 in the biflagellated alga *Chlamydomonas reinhardtii* increased significantly following deflagellation (PMID: 23991085). The *Chlamydomonas* *ida6* motility mutant with inner arm dynein defects could be rescued by transformation with the CCDC65 ortholog Fap250. Morpholino-based knockdown of *ccdc65* in zebrafish resulted in ciliopathy phenotypes and olfactory ciliary beat with either complete cilia paralysis or dyskinetic, faster beat rate (PMID: 24094744). A *Ccdc65* knockout mouse showed laterality defects consistent with a PCD phenotype (cardiac transposition and dilated lateral ventricle) (PMID: 35844805).\n\nIn summary, there is definitive evidence to support the gene-disease relationship of *CCDC65* with primary ciliary dyskinesia 27. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen Motile Ciliopathy GCEP on August 8th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/031c870b-0e47-4c9c-ac63-d3c041e29c80","GCISnapshot":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2024-09-30T21:08:49.509Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10102","date":"2024-08-08T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2278f96f-a3cf-4486-9396-ff49dcb5296c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7363717-7337-4a2a-bdef-822da733cd1f","type":"EvidenceLine","dc:description":"Undetailed respiratory phenotype","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7363717-7337-4a2a-bdef-822da733cd1f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Near absence of CDCC65 protein  detected in the sperm of the patient carrying the truncating c.1208del variant (p.Asn403IlefsTer9) compared to control cells \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d7363717-7337-4a2a-bdef-822da733cd1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37975235","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e15e1d2-5fb0-43e1-9530-0df8a2c9aa57","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033124.5(CCDC65):c.1208del (p.Asn403IlefsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2618589914"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2278f96f-a3cf-4486-9396-ff49dcb5296c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37975235","rdfs:label":"Jreijiri_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e15e1d2-5fb0-43e1-9530-0df8a2c9aa57"},"phenotypes":"obo:HP_0003251","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d7363717-7337-4a2a-bdef-822da733cd1f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d46320d9-ee4c-435a-a52c-bc4e47f6afb7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7040c5a0-3c69-445f-bbe2-e7ac3364dc60","type":"EvidenceLine","dc:description":"Undetailed respiratory phenotype and deficient expression evidence","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7040c5a0-3c69-445f-bbe2-e7ac3364dc60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37975235","allele":{"id":"https://genegraph.clinicalgenome.org/r/0299ad39-8792-4438-9527-b5d1b4877ec2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033124.5(CCDC65):c.1126C>T (p.Gln376Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384635756"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d46320d9-ee4c-435a-a52c-bc4e47f6afb7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37975235","rdfs:label":"Jreijiri_2","allele":{"id":"https://genegraph.clinicalgenome.org/r/0299ad39-8792-4438-9527-b5d1b4877ec2"},"phenotypeFreeText":"\n","phenotypes":"obo:HP_0003251","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7040c5a0-3c69-445f-bbe2-e7ac3364dc60_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1d95c787-889d-4ef8-b052-959636392b85_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4dd35f0-0e44-4986-a737-15aede85ab7c","type":"EvidenceLine","dc:description":"The variant is downscored due to undetailed phenotype mentioned in the PCD cohort","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4dd35f0-0e44-4986-a737-15aede85ab7c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant creates a premature translational stop signal (p.Glu220*) in the CCDC65 gene. It is expected to result in an absent or disrupted protein product.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d4dd35f0-0e44-4986-a737-15aede85ab7c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33479112","allele":{"id":"https://genegraph.clinicalgenome.org/r/194bf264-9ea4-4118-8817-e598ff2b97c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033124.5(CCDC65):c.658G>T (p.Glu220Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6543302"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1d95c787-889d-4ef8-b052-959636392b85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33479112","rdfs:label":"Shoemark_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/194bf264-9ea4-4118-8817-e598ff2b97c8"},"phenotypeFreeText":"PCD phenotype(from a PCD cohort)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4dd35f0-0e44-4986-a737-15aede85ab7c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8c74673b-aa56-4966-a162-c7688daa8d16_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df141a4c-81a2-4a01-86f5-8b4f006d150f","type":"EvidenceLine","dc:description":"Relatively high  gnomAD frequency in Ashkenazi Jewish","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df141a4c-81a2-4a01-86f5-8b4f006d150f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Photomicrographs of CCDC65 immunofluorescent staining in nasal epithelial cells revealing cytoplasmic and axonemal localization of the protein in normal cells compared to decreased expression in epithelial cells collected from the PCD subject\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/df141a4c-81a2-4a01-86f5-8b4f006d150f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24094744","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033124.5(CCDC65):c.877_878del (p.Ile293ProfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278910"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8c74673b-aa56-4966-a162-c7688daa8d16","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24094744","rdfs:label":"Austin-Tse_1","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"phenotypeFreeText":"Otitis media, sinus disease, bronchiectasis and low nNO\nNo situs inversus, fertility status  not ascertained\n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/df141a4c-81a2-4a01-86f5-8b4f006d150f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a0e3d6e3-10d0-487c-a98e-6a8b706a2482_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c7ad13c-32fd-4201-9df8-66991251e1c5","type":"EvidenceLine","dc:description":"This variant creates a premature translational stop signal (p.Arg305*) in the CCDC65 gene. It is expected to result in an absent or disrupted protein product. Whilst the phenotype is consistent with the diagnosis of PCD, no separate experiment confirmed the effect of the variant on the protein.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c7ad13c-32fd-4201-9df8-66991251e1c5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"yes","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3c7ad13c-32fd-4201-9df8-66991251e1c5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39004944","allele":{"id":"https://genegraph.clinicalgenome.org/r/be167bf6-ae9c-401d-81f5-3277d57f9264","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033124.5(CCDC65):c.913C>T (p.Arg305Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6543372"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/a0e3d6e3-10d0-487c-a98e-6a8b706a2482","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39004944","rdfs:label":"P1_Jat","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/be167bf6-ae9c-401d-81f5-3277d57f9264"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Wet cough, persistent nonseasonal rhinosinusitis starting before 6 months of age. Some stiff beating and some immotile cilia by HSVM.\n","phenotypes":"obo:HP_0033036","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3c7ad13c-32fd-4201-9df8-66991251e1c5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1b74403a-f4fb-423e-afd9-ae14c8de1721_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/751fbffe-ca4a-4989-95c3-83cdcb6dd097","type":"EvidenceLine","dc:description":"The variant is detected in one of five regions of homozygosity, GnomAD highest MAF is  0.004339 in Ashkenazi Jewish\n","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/751fbffe-ca4a-4989-95c3-83cdcb6dd097_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Photomicrographs of CCDC65 immunofluorescent staining in nasal epithelial cells revealing cytoplasmic and axonemal localization of the protein in normal cells compared to decreased expression in epithelial cells collected from the PCD subject\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/751fbffe-ca4a-4989-95c3-83cdcb6dd097_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23991085","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1b74403a-f4fb-423e-afd9-ae14c8de1721","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23991085","rdfs:label":"Horani_P1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"phenotypeFreeText":"the cilia beat pattern of ciliated cell clusters revealed stiff and hyperkinetic cilia with a limited cilia stroke compared to cilia from non-PCD controls\n","phenotypes":["obo:HP_0033036","obo:HP_0002205","obo:HP_0002110"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/751fbffe-ca4a-4989-95c3-83cdcb6dd097_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/59c55b12-1e09-43d8-bede-42a4990d8fec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e2f6b95-5bab-4680-8f48-e525509fd576","type":"EvidenceLine","dc:description":"The variant is a predicted null variant which is detected in homozygous state in a proband with consistent PCD phenotype","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e2f6b95-5bab-4680-8f48-e525509fd576_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant creates a premature translational stop signal (p.Arg305*) in the CCDC65 gene. It is expected to result in an absent or disrupted protein product.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8e2f6b95-5bab-4680-8f48-e525509fd576_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33479112","allele":{"id":"https://genegraph.clinicalgenome.org/r/be167bf6-ae9c-401d-81f5-3277d57f9264"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/59c55b12-1e09-43d8-bede-42a4990d8fec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33479112","rdfs:label":"Shoemark_2","allele":{"id":"https://genegraph.clinicalgenome.org/r/be167bf6-ae9c-401d-81f5-3277d57f9264"},"phenotypeFreeText":"PCD phenotype (PCD cohort)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e2f6b95-5bab-4680-8f48-e525509fd576_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c2f606e3-96e2-43d4-8942-b805c1fe5120_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0737f6e1-a572-4070-967a-ff66d77b7ae4","type":"EvidenceLine","dc:description":"Homozygosity and relatively high gnomAD frequency","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0737f6e1-a572-4070-967a-ff66d77b7ae4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Photomicrographs of CCDC65 immunofluorescent staining in nasal epithelial cells revealed cytoplasmic and axonemal localization of the protein in normal cells compared to decreased expression in epithelial cells collected from the PCD subject\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0737f6e1-a572-4070-967a-ff66d77b7ae4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33479112","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c2f606e3-96e2-43d4-8942-b805c1fe5120","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33479112","rdfs:label":"Shoemark_3","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"phenotypeFreeText":"PCD phenotype (in a PCD cohort)","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0737f6e1-a572-4070-967a-ff66d77b7ae4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45e8b0b0-fd1c-452d-8914-495743db3a94_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1d35863-4db7-4099-ad9b-fb52045a5959","type":"EvidenceLine","dc:description":"Relatively high gnomAD frequency in Ashkenazi Jewish","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1d35863-4db7-4099-ad9b-fb52045a5959_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Photomicrographs of CCDC65 immunofluorescent staining in nasal epithelial cells revealing cytoplasmic and axonemal localization of the protein in normal cells compared to decreased expression in epithelial cells collected from the PCD subject\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e1d35863-4db7-4099-ad9b-fb52045a5959_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24094744","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45e8b0b0-fd1c-452d-8914-495743db3a94","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24094744","rdfs:label":"Austin-Tse_2","allele":{"id":"https://genegraph.clinicalgenome.org/r/f619775e-5a30-489a-9b4a-f256030127cd"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e1d35863-4db7-4099-ad9b-fb52045a5959_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.7},{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0a8966a-c418-4558-a80e-40e5d97c96c7","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7239b9f-7389-429f-8601-5c2e12729a2d","type":"Finding","dc:description":"ccdc65 morphant cilia show normal dynein arm ultrastructure in averaged doublets \nKymograms of ccdc65 morphant olfactory cilia beat shows either complete cilia paralysis or dyskinetic, faster beat rate, a similar phenotype to those observed in CCDC65 deficient patients\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24094744","rdfs:label":"Morpholino knockdown of ccdc65 produces ciliopathy phenotype","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1ca6f321-287f-4b56-8524-42c4c372c5e0","type":"EvidenceLine","dc:description":" The study aim was to investigate CCDC65 as a tumor suppressor gene. Therefore, the ciliopathy phenotype (cardiac transposition and dilated lateral ventricle) was not investigated in detail.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff46e374-9777-4e6e-baca-7c06ed461ca8","type":"Finding","dc:description":"Cardiac transposition and dilated lateral ventricle recapitulated situs inversus and hydrocephalus reported in PCD patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35844805","rdfs:label":"CCDC65 knockout  leads to Early Death of Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0a16e86e-a8b4-48a5-b96a-1e8f60d5bc14","type":"EvidenceLine","dc:description":"Rescuing in non-human model organism","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39d8b905-7f19-4cd3-b581-8b520eef4e29","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24094744","rdfs:label":"Rescuing the Chlamydomonas mutant","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea796d72-93f4-428b-80e0-89c7e24f569d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/72730d0b-65b8-4dc3-b41c-b734fb8c368a","type":"FunctionalAlteration","dc:description":"\nExamining the cilia beat pattern of ciliated cell clusters revealed stiff and hyperkinetic cilia, with a limited cilia stroke compared to cilia from non-PCD controls\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23991085","rdfs:label":"ciliary beat of airway epithelial cells."}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/662ab516-ba5f-46aa-97b2-ef4c8f3201a5_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78696024-8f86-49b3-b462-841a52b8b4c8","type":"EvidenceLine","dc:description":"The experiment indicated the role of CCDC65  in nexin-dynein regulatory complex (DRC) assembly throgh its interaction with GAS8, another DRC assembly factor\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42de9195-599f-41b3-99d7-e9596ab0ecd3","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23991085","rdfs:label":"CCDC65 is involved in DRC assembly","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6ebabe0e-bbf1-4d05-8c6b-bc9123076106","type":"EvidenceLine","dc:description":"Two separate experiments validated the expression of CCDC65 in PCD relevant tissues and during ciliogenesis","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89c100e3-18f7-4b4d-930b-63e81dd4c0f2","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23991085","rdfs:label":"Expression of CCDC65 during ciliogenesis","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":9083,"specifiedBy":"GeneValidityCriteria10","strengthScore":12.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/13DcFmCpX0Y","type":"GeneValidityProposition","disease":"obo:MONDO_0014215","gene":"hgnc:29937","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_662ab516-ba5f-46aa-97b2-ef4c8f3201a5-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}